Error: Could not add to watchlist. X

Progenics Pharmaceuticals Inc

+ Watchlist
PGNX:US
NASDAQ GS
8.66
USD
0.20
2.36%
As of 20:10:00 ET on 08/01/2015.
Open
8.50
Day Range
8.26 - 9.11
Volume
2,030,139
Previous Close
8.46
52Wk Range
4.26 - 11.15
1 Yr Return
86.64%
Open
8.50
Day Range
8.26 - 9.11
Volume
2,030,139
Previous Close
8.46
52Wk Range
4.26 - 11.15
1 Yr Return
86.64%
YTD Return
14.55%
Current P/E Ratio (TTM)
199.90
Earnings per Share (USD) (TTM)
0.04
Market Cap (m USD)
603.125
Shares Outstanding (m)
69.645
Price/Sales (TTM)
13.82
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
Profile
Progenics Pharmaceuticals, Inc. is a biopharmaceutical company. The Company develops and distributes therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases. Progenics' principal programs are directed toward supportive care, virology (human immunodeficiency virus and hepatitis C virus infections), and oncology.
ADDRESS
777 Old Saw Mill River Road
Tarrytown, NY 10591
United States
PHONE
1-914-789-2800
  • Mark Robert Baker
    Chief Executive Officer
  • Vivien Wong
    Exec VP:Development
  • Nitya G Ray
    Senior VP:Manufacturing
  • Angelo W Lovallo
    VP:Finance/Treasurer
  • Ann Marie Assumma
    VP:Regulatory Affairs
Show More